By using this website you agree that we use cookies. You can find out more in the privacy policy.

Arizona Tribune - Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Arizona Tribune
×
NYSE - LSE
BCC -4.57% 79 $
RBGPF 0.44% 63.75 $
CMSC -0.04% 22.82 $
CMSD -0.61% 23.06 $
NGG -1.71% 85.98 $
RYCEF -2.68% 14.9 $
RELX -0.59% 35.8 $
GSK -5.97% 51.4 $
BCE -1.03% 23.26 $
RIO -2.07% 96.49 $
VOD -0.98% 15.34 $
JRI -0.55% 12.74 $
AZN -0.8% 185.2 $
BP 0.96% 46.8 $
BTI -1.78% 57.45 $
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

BOULEVARD 14.08.2025

ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg

Text size:

One-on-One Meetings

Aspire will also host virtual one-on-ones with investors on Wednesday, August 20 and Thursday, August 21, 2025. To register for the presentation or one-on ones, visit https://sidoti.com/events.

A replay of the presentation will be available on the investor relations section of Aspire's website at https://ir.aspirebiolabs.com/events/

About Aspire Biopharma, Inc.

Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit www.aspirebiolabs.com.

Aspire Biopharma Holdings, Inc.

Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]

SOURCE: Aspire Biopharma Holdings, Inc.



View the original press release on ACCESS Newswire

Ch.P.Lewis--AT

Featured

Manila landfill fire leaves locals gasping

Manila landfill fire leaves locals gasping
Cambodia deports more than 600 Thais linked to cyberscams: minister

Cambodia deports more than 600 Thais linked to cyberscams: minister
Afghan women footballers celebrate 'historic moment'

Afghan women footballers celebrate 'historic moment'
Afghan women footballers celebrate 'historical moment'

Afghan women footballers celebrate 'historical moment'